Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

This study has been completed.
Information provided by:
The Center for Rheumatic Disease, Allergy, & Immunology Identifier:
First received: December 28, 2006
Last updated: September 18, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)